CDCA2 Antikörper (AA 361-450)
Kurzübersicht für CDCA2 Antikörper (AA 361-450) (ABIN872339)
Target
Alle CDCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 361-450
-
Verwendungszweck
- CDCA2 Polyclonal Antibody
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDCA2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CDCA2 (Cell Division Cycle Associated 2 (CDCA2))
-
Andere Bezeichnung
- CDCA2
-
Hintergrund
-
Synonyms: PPP1R81, Repo-Man, Cell division cycle-associated protein 2, Recruits PP1 onto mitotic chromatin at anaphase protein, CDCA2
Background: Regulator of chromosome structure during mitosis required for condensin-depleted chromosomes to retain their compact architecture through anaphase. Acts by mediating the recruitment of phopsphatase PP1-gamma subunit (PPP1CC) to chromatin at anaphase and into the following interphase. At anaphase onset, its association with chromatin targets a pool of PPP1CC to dephosphorylate substrates.
-
Gen-ID
- 157313
-
UniProt
- Q69YH5
Target
-